"10.1371_journal.pone.0014047","plos one","2010-11-18T00:00:00Z","Helen Waller-Evans; Simone Pr√∂mel; Tobias Langenhan; John Dixon; Dirk Zahn; William H Colledge; Joanne Doran; Mark B L Carlton; Ben Davies; Samuel A J R Aparicio; Johannes Grosse; Andreas P Russ","Department of Biochemistry and Magdalen College, University of Oxford, Oxford, United Kingdom; Takeda Cambridge Ltd, Cambridge, United Kingdom; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Department of Pathology and Laboratory Medicine and BC Cancer Research Centre, University of British Columbia, Vancouver, Canada","Conceived and designed the experiments: HWE SP MC SA AR. Performed the experiments: HWE SP TL JD DZ WC JD BD AR. Analyzed the data: HWE SP TL AR. Contributed reagents/materials/analysis tools: JG. Wrote the paper: AR.","JDi, DZ, JDo, MBLC, and JG are employees of Takeda Cambridge Ltd. SAJRA is a consultant for Takeda Cambridge Ltd. MBLC, SAJRA, and APR are founders of Paradigm Therapeutics Ltd., which was acquired by Takeda Cambridge Ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2010","11","Helen Waller-Evans","HWE",12,TRUE,5,8,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
